Cosmo announces successful Phase III clinical trial of Lumeblue™ in China

Cosmo Pharmaceuticals N.V. / Key word(s): Study resultsCosmo announces successful Phase III clinical trial of Lumeblue™ in China 14.12.2022 / 06:00 GMT/BST Dublin, Ireland – 14 December 2022: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) today announced the successful phase III clinical trial of Lumeb...

Related Keywords

China ,Ireland ,Dublin ,Falk Gmbh ,Hazel Winchester ,Cosmo Pharmaceuticalsnv Key ,Cosmo Pharmaceuticals ,Medtronic ,Red Hill Biopharma Ltd ,Holdings Limited ,China Medical System ,Red Hill Biopharma ,